title: Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia.
abstract: Treatment of human immunodeficiency virus type 1 (HIV-1)-infected patients with combination drug regimens results in a reduction of plasma viral load to levels below the limit of detection. To investigate the genomic fluctuations in HIV-1 populations from long-term responders to antiviral therapies we analyzed the viral sequence evolution of env and pol genes from sequential peripheral blood mononuclear cell (PBMC) DNA samples of three infected patients. Analyses of sequences covering the V3 and flanking env regions obtained from blood samples at the beginning of the therapy and at 14 or 24 months from baseline revealed that HIV-1 quasispecies continue to evolve in the three patients following combination antiretroviral therapy. Minor drug-resistant mutant subpopulations were also searched for and found in one patient. Interestingly, no minor resistant subpopulations were found in the other two patients despite the fact that they showed evidence of ongoing viral replication. Finally, the genetic analysis of the env gene shows a reduction in PBMC env viral population diversity after long-term response to the therapy in all the patients analyzed.
authors: Laboratori de Retrovirologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain. mamartz@ns.hugtip.scs.es
authors: M A
authors: MA
authors: Martínez
authors: M
authors: M
authors: Cabana
authors: A
authors: A
authors: Ibáñez
authors: B
authors: B
authors: Clotet
authors: A
authors: A
authors: Arnó
authors: L
authors: L
authors: Ruiz
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D019143:Evolution, Molecular; D015752:Genes, env; D015699:HIV Envelope Protein gp120 / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use; D010446:Peptide Fragments / Q000235:genetics*; D010802:Phylogeny; D013997:Time Factors; D014766:Viremia / Q000821:virology*
chemical_list: D019380:Anti-HIV Agents; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D009705:Nucleosides; D010446:Peptide Fragments; D054303:HIV Reverse Transcriptase